158 related articles for article (PubMed ID: 38358152)
1. Clinicopathological and immunohistochemical characterization of gastrointestinal stromal tumour at four tertiary health centers in Nigeria using CD117, DOG1, and human epidermal growth factor receptor-2 biomarkers.
Rasheed MW; Abiodun AE; Eziagu UB; Idowu NA; Kabiru A; Adegboye TA; Oluogun WA; Ayoade AA
Ann Afr Med; 2023; 22(4):501-507. PubMed ID: 38358152
[TBL] [Abstract][Full Text] [Related]
2. CLINICOPATHOLOGICAL AND IMMUNO-HISTOCHEMICAL CHARACTERIZATION OF GASTROINTESTINAL STROMAL TUMOUR AT FOUR TERTIARY HEALTH CENTERS IN NIGERIA USING CD117, DOG1, AND HER-2 BIOMARKERS.
Rasheed MW; Afolayan EA; Uchechukwu BE; Najeem AI; Kabiru A; Adegboye AT; Oluogun WA; Adekunle AA
West Afr J Med; 2023 Nov; 40(11 Suppl 1):S25. PubMed ID: 37978874
[TBL] [Abstract][Full Text] [Related]
3. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors.
Sahu KK; Tapadia R; Kini JR; Pai RR; Kini H; Nirupama M; Pooja KS
J Cancer Res Ther; 2019; 15(1):138-141. PubMed ID: 30880769
[TBL] [Abstract][Full Text] [Related]
4. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
Sui XL; Wang H; Sun XW
Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
[TBL] [Abstract][Full Text] [Related]
5. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
6. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
[TBL] [Abstract][Full Text] [Related]
7. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.
Dailey DD; Ehrhart EJ; Duval DL; Bass T; Powers BE
J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711
[TBL] [Abstract][Full Text] [Related]
8. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
Şahin S; Ekinci Ö; Seçkin S; Dursun A
Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
[TBL] [Abstract][Full Text] [Related]
9. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
Jang BG; Lee HE; Kim WH
Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour.
Parfitt JR; Rodriguez-Justo M; Feakins R; Novelli MR
Histopathology; 2008 Jun; 52(7):816-23. PubMed ID: 18494611
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
12. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.
Lee CH; Liang CW; Espinosa I
Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677
[TBL] [Abstract][Full Text] [Related]
13. DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.
Wada T; Tanabe S; Ishido K; Higuchi K; Sasaki T; Katada C; Azuma M; Naruke A; Kim M; Koizumi W; Mikami T
World J Gastroenterol; 2013 Dec; 19(47):9133-6. PubMed ID: 24379641
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor.
Liu FY; Qi JP; Xu FL; Wu AP
World J Gastroenterol; 2006 Jul; 12(26):4161-5. PubMed ID: 16830365
[TBL] [Abstract][Full Text] [Related]
15. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
Swalchick W; Shamekh R; Bui MM
Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
[TBL] [Abstract][Full Text] [Related]
16. Analysis of clinicopathological and immunohistochemical parameters and correlation of outcomes in gastrointestinal stromal tumors.
Varshney VK; Gupta RK; Saluja SS; Tyagi I; Mishra PK; Batra VV
Indian J Cancer; 2019; 56(2):135-143. PubMed ID: 31062732
[TBL] [Abstract][Full Text] [Related]
17. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors.
González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL
Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840
[TBL] [Abstract][Full Text] [Related]
18. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
[TBL] [Abstract][Full Text] [Related]
19. A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma.
Riddle ND; Gonzalez RJ; Bridge JA; Antonia S; Bui MM
Cancer Control; 2011 Jul; 18(3):152-9. PubMed ID: 21666577
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features].
Kovács M; Nagy P; Pák G; Fehér J
Orv Hetil; 2005 Jun; 146(26):1375-81. PubMed ID: 16052979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]